FDA 510(k) clearance gives CurveBeam AI first step toward CT bone-health SaaS
FDA clears CurveBeam AI’s BoneVue CT bone-density technology, while a second HiRise clearance remains necessary for its planned BMD SaaS launch.
Medical Devices & Diagnostics
Pharma & Biotech
Obodence at WCO 2026: Samsung Bioepis sharpens the clinical case for SB16 adoption
Samsung Bioepis presented new SB16 subgroup data at WCO 2026. Read what it means for Obodence adoption, biosimilar trust, and osteoporosis care.